Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950114-95-000126
Filing Date
1995-06-29
Accepted
1995-06-29 00:00:00
Documents
12
Period of Report
1995-03-31
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 1994 FORM 10-K405 10-K405 147886
2 FIFTH AMENDMENT TO CREDIT AGREEMENT EX-4.(L) 46830
3 SIXTH AMENDMENT TO CREDIT AGREEMENT EX-4.(M) 47526
4 LOAN AND SECURITY AGREEMENT EX-4.(N) 157086
5 REVOLVING LOAN NOTE EX-4.(O) 13879
6 TERM NOTE EX-4.(P) 13886
7 FORM OF CAPITAL EQUIPMENT NOTE EX-4.(Q) 13465
8 DEED OF TRUST AND SECURITY AGREEMENT EX-4.(R) 96492
9 STATEMENT RE COMPUTATION OF PER SHARE EARNINGS EX-11 4239
10 SUBSIDIARIES OF THE REGISTRANT EX-21 491
11 CONSENT OF EXPERT EX-23 812
12 FINANCIAL DATA SCHEDULE EX-27 2310
  Complete submission text file 0000950114-95-000126.txt   547506
Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144
Business Address 2503 SOUTH HANLEY RD ST LOUIS MO 63144 3146456600
KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)

EIN.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K405 | Act: 34 | File No.: 001-09601 | Film No.: 95551152
SIC: 2834 Pharmaceutical Preparations